ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,729Medicare Part D Prescriptions Filled, Including Refills

Rank: 23 out of 198

$610K Total Retail Price of All Prescriptions

Rank: 42 out of 198

467 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 467 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 467 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 13,744 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 704 691 1 1
OMEPRAZOLE 673 619 2 3
FUROSEMIDE 536 529 3 5
WARFARIN SODIUM 535 511 4 7
SIMVASTATIN 484 442 5 2
METOPROLOL SUCCINATE 334 301 6 11
METOPROLOL TARTRATE 333 333 7 10
AMLODIPINE BESYLATE 310 310 8 4
POTASSIUM CHLORIDE 307 287 9 9
LISINOPRIL 306 285 10 6
LOSARTAN POTASSIUM 289 284 11 18
MONOJECT INSULIN SAFETY SYRNG 281 281 10 12 118
TRAMADOL HCL 244 196 13 15
PAROXETINE HCL 237 231 14 65
DIGOXIN 212 212 15 43
ATORVASTATIN CALCIUM 206 184 16 12
HYDROCODONE-ACETAMINOPHEN 182 149 S3 17 8
PANTOPRAZOLE SODIUM 176 173 18 31
ZOLPIDEM TARTRATE 174 165 19 22
METFORMIN HCL 161 144 20 13
GABAPENTIN 161 157 20 14
DIOVAN 156 150 22 34
GLIMEPIRIDE 151 150 23 35
TORSEMIDE 146 143 24 75
ALLOPURINOL 140 115 25 23
CARVEDILOL 138 134 26 24
NAMENDA 131 131 27 33
OXYBUTYNIN CHLORIDE 123 122 28 89
FENOFIBRATE 120 120 29 61
DONEPEZIL HCL 111 111 30 28
ROPINIROLE HCL 109 103 31 74
HYDROCHLOROTHIAZIDE 104 93 32 16
LISINOPRIL-HYDROCHLOROTHIAZIDE 102 90 33 38
TAMSULOSIN HCL 101 95 34 27
TRIAMTERENE-HCTZ 101 94 34 32
PREDNISONE 100 92 36 29
INSULIN SYRINGE 98 90 37 95
LANTUS 97 93 38 46
CLONIDINE HCL 96 96 39 52
MECLIZINE HCL 95 83 40 129
LOSARTAN-HYDROCHLOROTHIAZIDE 91 91 41 49
ATENOLOL 91 81 41 17
CEPHALEXIN 90 76 43 108
ALENDRONATE SODIUM 87 87 44 21
DIOVAN HCT 83 83 45 88
FLUTICASONE PROPIONATE 78 70 46 39
VENLAFAXINE HCL ER 77 59 47 84
CALCITRIOL 77 77 47 179
MIRTAZAPINE 77 74 47 44
TIZANIDINE HCL 76 49 50 171
KLOR-CON M10 75 75 51 125
AMOX TR-POTASSIUM CLAVULANATE 75 68 51 154
AZITHROMYCIN 74 70 53 56
CELEBREX 73 73 54 59
QUETIAPINE FUMARATE 72 65 55 76
RISPERIDONE 71 69 56 82
PRAVASTATIN SODIUM 70 70 57 19
CLOPIDOGREL 67 67 58 42
POLYETHYLENE GLYCOL 3350 63 47 59 41
FAMOTIDINE 63 61 59 57
JANUVIA 60 60 61 86
TRAZODONE HCL 60 58 61 50
NEXIUM 60 60 61 40
CIPROFLOXACIN HCL 59 54 64 55
VESICARE 58 50 65 77
SERTRALINE HCL 58 55 65 25
CITALOPRAM HBR 57 45 67 20
OXYBUTYNIN CHLORIDE ER 57 46 67 109
EXFORGE 56 56 69 272
DILTIAZEM 24HR CD 56 56 69 126
PRAMIPEXOLE DIHYDROCHLORIDE 56 56 69 157
BISOPROLOL FUMARATE 54 50 72 87
AMITRIPTYLINE HCL 51 46 R 73 69
CYMBALTA 50 50 74 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 5, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.